NICOTINAMIDE DECREASES NITRIC-OXIDE PRODUCTION AND PARTIALLY PROTECTSHUMAN PANCREATIC-ISLETS AGAINST THE SUPPRESSIVE EFFECTS OF COMBINATIONS OF CYTOKINES
Dl. Eizirik et al., NICOTINAMIDE DECREASES NITRIC-OXIDE PRODUCTION AND PARTIALLY PROTECTSHUMAN PANCREATIC-ISLETS AGAINST THE SUPPRESSIVE EFFECTS OF COMBINATIONS OF CYTOKINES, Autoimmunity, 19(3), 1994, pp. 193-198
It has been recently reported that human pancreatic islets in tissue c
ulture produce nitric oxide (NO) and show a decreased function when ex
posed for 6 days to combinations of cytokines (interleukin-1 beta (IL-
1 beta)+ tumor necrosis factor-alpha (TNF-alpha)+ interferon-gamma (IF
N-gamma). Here we study the effects of nicotinamide (Nic; 10 or 20 mmo
l/l) on these deleterious effects of cytokines (50 U/ml IL-1 beta + 10
00 U/ml TNF-alpha+ 1000 U/ml IFN-gamma). Islets were isolated from 8 h
uman pancreata at the Central Unit of the P-cell Transplant, Brussels,
sent to Uppsala and, after 3-5 days in culture, exposed for 6 additio
nal days to the cytokines and/or Nic. The cytokines induced a 6-fold i
ncrease in islet NO production (P < 0.001), and this effect was partia
lly counteracted by Nic (50-60% decrease in NO production; P < 0.001).
The cytokines severely decreased the islet insulin content and glucos
e-induced insulin release (16.7 mmol/l glucose; 90% decrease; P < 0.00
1). Both these effects of cytokines were partially counteracted by Nic
, especially at the highest concentration (20 mmol/l; 2-4-fold increas
e compared to islets exposed to cytokines alone; P < 0.01). Nic by its
elf did not affect the insulin content or insulin release by control i
slets. In conclusion, the present data indicate that Nic counteracts t
he deleterious effects of cytokines on human pancreatic islets. This e
ffect of Nic may be relevant for the beneficial effects of the drug in
early IDDM.